Baculoviral IAP Repeat Containing 5 (BIRC5) is expressed in 60% of adult AML patient samples and is more frequently expressed than FLT-3 [9], PRAME [10] or Wilms’ Tumour gene 1 (WT1) [11]. This evidence concerns the gene BIRC5 and acute myeloid leukemia.